Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer

被引：38

作者：

Liu, Xuan ^{[1
,2
,3
]}

Yu, Jiahui ^{[3
]}

Song, Shangjin ^{[3
]}

Yue, Xiaoqiang ^{[3
]}

Li, Qi ^{[1
,2
]}

机构：

[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai 201203, Peoples R China

[2] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Canc Inst, Shanghai 201203, Peoples R China

[3] Second Mil Med Univ, Changzheng Hosp, Dept Tradit Chinese Med, Shanghai 200003, Peoples R China

来源：

ONCOTARGET | 2017年 / 8卷 / 63期

基金：

中国国家自然科学基金;

关键词：

PAR-1; cancer; carcinogenesis; invasion; metastasis; EPITHELIAL-MESENCHYMAL TRANSITION; THROMBIN RECEPTOR; MATRIX METALLOPROTEINASE-1; PROSTATE-CANCER; TISSUE FACTOR; PROGENITOR CELLS; PROGNOSTIC VALUE; MELANOMA GROWTH; SIGNALING AXIS; FACTOR VIIA;

D O I：

10.18632/oncotarget.21015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PAR-1 is expressed not only in epithelium, neurons, astrocytes, immune cells, but also in cancer-associated fibroblasts, ECs (epithelial cells), myocytes of blood vessels, mast cells, and macrophages in tumor microenvironment, whereas PAR-1 stimulates macrophages to synthesize and secrete thrombin as well as other growth factors, resulting in enhanced cell proliferation, tumor growth and metastasis. Therefore, considerable effort has been devoted to the development of inhibitors targeting PAR-1. Here, we provide a comprehensive review of PAR-1's role in cancer invasiveness and dissemination, as well as potential therapeutic strategies targeting PAR-1 signaling.

引用

页码：107334 / 107345

页数：12

共 50 条

[1] Cleavage of protease-activated receptor-1 (PAR-1) and platelet activation by α- and γ-thrombins
Nyarko, KA
Freedman, J
Song, YQ
Gentry, PA
Ofosu, FA
[J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 817 - 817
[2] De- and resensitization of protease-activated receptor-1 (PAR-1) in rat astrocytes
Ubl, JJ
Sergeeva, M
Reiser, G
[J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 : S73 - S73
[3] Role of protease-activated receptor-1 (PAR-1) in the glomerular filtration barrier integrity
Medipally, Ajay
Xiao, Min
Biederman, Laura
Satoskar, Anjali A.
Ivanov, Iouri
Rovin, Brad
Parikh, Samir
Kerlin, Bryce A.
Brodsky, Sergey, V
[J]. PHYSIOLOGICAL REPORTS, 2022, 10 (15):
[4] Protease-activated receptor-1 (PAR-1) expression correlates with a malignant phenotype in human melanoma
Silini, A.
Ardinghi, C.
Carraro, F.
Naldini, A.
Bani, M. R.
Giavazzi, R.
[J]. THROMBOSIS RESEARCH, 2007, 120 : S142 - S143
[5] Pregnancy Specific Activation of Neutrophils in Preeclampsia via Protease-Activated Receptor-1 (PAR-1).
Nugent, William H.
Teves, Maria E.
Washington, Sonya L.
Strauss, Jerome F., III
Walsh, Scott W.
[J]. REPRODUCTIVE SCIENCES, 2016, 23 : 305A - 305A
[6] Protease-activated receptor 1 (PAR1): a promising target for the treatment of glioblastoma?
de Almeida, Vitor Hugo
Monteiro, Robson Q.
[J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1274 - S1280
[7] Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype
Antonietta Silini
Carmen Ghilardi
Camilla Ardinghi
Sergio Bernasconi
Paolo Oliva
Fabio Carraro
Antonella Naldini
Maria Rosa Bani
Raffaella Giavazzi
[J]. Clinical & Experimental Metastasis, 2010, 27 : 43 - 53
[8] Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma
Tas, Faruk
Bilgin, Elif
Karabulut, Senem
Erturk, Kayhan
Duranyildiz, Derya
[J]. BBA CLINICAL, 2016, 5 : 166 - 169
[9] Protease Activated Receptor-1 (PAR-1) Impedes Tumor Progression
Adams, Gregory N.
Weston, Haley
Rosenfeldt, Leah
Frederick, Malinda
Palumbo, Joseph S.
[J]. BLOOD, 2016, 128 (22)
[10] Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype
Silini, Antonietta
Ghilardi, Carmen
Ardinghi, Camilla
Bernasconi, Sergio
Oliva, Paolo
Carraro, Fabio
Naldini, Antonella
Bani, Maria Rosa
Giavazzi, Raffaella
[J]. CLINICAL & EXPERIMENTAL METASTASIS, 2010, 27 (01) : 43 - 53

← 1 2 3 4 5 →